Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,815,937 papers from all fields of science
Search
Sign In
Create Free Account
Haliclona
Known as:
Haliclonas
A genus of SPONGES in the family Chalinidae characterized by unispicular secondary lines in the choanosomal skeleton.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Microbiological
aspects of radiation effects
physiological aspects
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Antimicrobial activity of marine sponges against coagulase-negative staphylococci isolated from bovine mastitis.
M. Laport
,
P. R. Marinho
,
+5 authors
M. Giambiagi-deMarval
Veterinary Microbiology
2012
Corpus ID: 24054847
2010
2010
JBIR-31, a new teleocidin analog, produced by salt-requiring Streptomyces sp. NBRC 105896 isolated from a marine sponge
M. Izumikawa
,
S. Khan
,
H. Komaki
,
M. Takagi
,
K. Shin‐ya
Journal of antibiotics (Tokyo. )
2010
Corpus ID: 44364026
JBIR-31, a new teleocidin analog, produced by salt-requiring Streptomyces sp. NBRC 105896 isolated from a marine sponge
2010
2010
Streptomyces tateyamensis sp. nov., Streptomyces marinus sp. nov. and Streptomyces haliclonae sp. nov., isolated from the marine sponge Haliclona sp.
S. Khan
,
T. Tamura
,
M. Takagi
,
K. Shin‐ya
International Journal of Systematic and…
2010
Corpus ID: 10367049
Three Gram-positive, NaCl-requiring actinobacteria were isolated from a marine sponge, Haliclona sp., collected from the coast of…
Expand
2009
2009
Convergent Antifouling Activities of Structurally Distinct Bioactive Compounds Synthesized Within Two Sympatric Haliclona Demosponges
K. Roper
,
H. Beamish
,
M. Garson
,
G. Skilleter
,
B. Degnan
Marine Biotechnology
2009
Corpus ID: 22877117
A wide range of sessile and sedentary marine invertebrates synthesize secondary metabolites that have potential as industrial…
Expand
2007
2007
Antileishmanial potential of a marine sponge, Haliclona exigua (Kirkpatrick) against experimental visceral leishmaniasis
A. Dube
,
Nasib Singh
,
A. K. Saxena
,
V. Lakshmi
Parasitology Research
2007
Corpus ID: 24229613
In this study, we are reporting antileishmanial activity of a marine sponge Haliclona exigua, belonging to phylum Porifera. The…
Expand
2004
2004
Population dynamics of a mutualistic interaction between the sponge Haliclona caerulea and the red alga Jania adherens
J. Carballo
,
E. Ávila
2004
Corpus ID: 59957716
A population of the association between the haplosclerid sponge Haliclona caerulea and the red algae Jania adherens was studied…
Expand
2002
2002
Isolation of Haliclonamides: New Peptides as Antifouling Substances from a Marine Sponge Species, Haliclona
Y. Sera
,
K. Adachi
,
K. Fujii
,
Y. Shizuri
Marine Biotechnology
2002
Corpus ID: 37862431
Bioassay-guided fractionation of an extract of a marine sponge species, Haliclona, led to the isolation and identification of new…
Expand
2001
2001
A new isoquinoline alkaloid from the marine sponge Haliclona species.
M. Rashid
,
K. Gustafson
,
M. Boyd
Journal of Natural Products
2001
Corpus ID: 30431212
Two isoquinoline alkaloids, including the new compound 1, were isolated from the cytotoxic fractions of an aqueous extract of the…
Expand
1996
1996
Total Synthesis of (+)-Papuamine: An Antifungal Pentacyclic Alkaloid from a Marine Sponge, Haliclona sp.
A. Barrett
,
M. Boys
,
T. Boehm
Journal of Organic Chemistry
1996
Corpus ID: 42774319
The total synthesis of (+)-papuamine, the antipode of the C(2)-symmetric, optically active, pentacyclic diamine natural product…
Expand
1985
1985
Bioactive proteins from marine sponges: screening of sponge extracts for hemagglutinating, hemolytic, ichthyotoxic and lethal properties and isolation and characterization of hemagglutinins.
D. Mebs
,
I. Weiler
,
H. Heinke
Toxicon
1985
Corpus ID: 10670606
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE